Fondaparinux Sodium

Spécifications

114870-03-0Numéro CAS

686-283-7Numéro CE

decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxyoxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulNom IUPAC

C31H43N3Na10O49S8Formule chimique

1728.1 g/molMasse molaire

Fondaparinux sodium; 114870-03-0; Arixtra; Quixidar; Fondaparin sodium; SR-90107A; X0Q6N9USOZ; fondaparinux sodico; fondaparinux sodique; Fondaparinux sodium for assay; Fondaparinux sodium identification; SR 90107A DECASODIUM SALT; SR-90107A DECASODIUM SALT; IC-851589; CHEBI:31632; DTXSID501027612; fondaparinuxum natricum; RefChem:55229; B01AX05; DTXCID301513201; Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-O-beta-D-glucopyra-nuronosyl-(1->4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt; Org 31540; MFCD06794972; SR 90107A; Org-31540; Fondaparinux (sodium); alpha-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-->4)-O-beta-D-glucopyranuronosyl-(1-->4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-->4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-->4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10); Xantidar; Arixtra (TN); Fondaparinux Sodium Salt; UNII-X0Q6N9USOZ; Fondaparin sodium;SR-90107A; Fondaparinux sodium [USAN]; Fondaparinux sodium?; Fondaparinux sodium [USAN:INN:BAN]; GSK-576428; SR-90107; Epitope ID:150913; SCHEMBL4937; orb1223419; orb1303188; CHEMBL1200644; FONDAPARINUX SODIUM [MI]; FONDAPARINUX SODIUM [INN]; FONDAPARINUX SODIUM [JAN]; C31H43N3Na10O49S8; FONDAPARINUX SODIUM [MART.]; Fondaparinux sodium (JAN/USP/INN); FONDAPARINUX SODIUM [USP-RS]; FONDAPARINUX SODIUM [WHO-DD]; AKOS005146286; FONDAPARINUX SODIUM [EMA EPAR]; CCG-270693; EBC-153096; OF04094; FONDAPARINUX SODIUM [ORANGE BOOK]; AS-80003; SY028588; FONDAPARINUX SODIUM [USP MONOGRAPH]; T4076; C71476; D01844; F799841; Q421218; alpha-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), decasodium salt; Methly O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt; Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(14)-O-b-D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoami no)-a-D-glucopyranosyl-(14)-O-2-O-sulfo-a-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-a-D-glucopyranoside 6-(hydrogen s; Fondaparinux natriSynonymes